Component
Human pyrroline-5-carboxylate reductase 3 / PYCR3 / PYCRL
Context-specific entity; species, compartment and exposure are stated on each claim.
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Human PYCRL/PYCR3 localized predominantly to the cytosol in the tested melanoma cells and was more efficient with NADPH in the biochemical comparison.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Lu1205 cell fractionation and recombinant human PYCRL kinetics.
- limitations
- The melanoma routing pattern is not asserted to apply identically in every human tissue.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- The cytosolic version has different preferences from the mitochondrial enzymes.
- primary_references
- Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 30–36
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Lu1205 cell fractionation and recombinant human PYCRL kinetics. · source_derived_draft · unverified_draft
## l-proline-pycr3-reduction The cytosolic version has different preferences from the mitochondrial enzymes. Human PYCRL/PYCR3 localized predominantly to the cytosol in the tested melanoma cells and was more efficient with NADPH in the biochemical comparison. Model: Lu1205 cell fractionation and recombinant human PYCRL kinetics. Limitations: The melanoma routing pattern is not asserted to apply identically in every human tissue. Evidence access: Primary full text Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
Complete structured claim and evidence
Where it participates (unsigned role)
Isotope tracing with gene silencing linked glutamine/glutamate-derived proline mainly to PYCR1/PYCR2 and ornithine-derived proline mainly to PYCRL in human melanoma cells.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Lu1205 cells; 1 mM labeled precursors for eight hours; ornithine labeling required omission of extracellular proline.
- limitations
- The ornithine experiment used conditions the authors regarded as likely nonphysiological; no universal exclusive routing rule is inferred.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Two precursor routes can feed the same product through differently placed enzymes.
- primary_references
- Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 38–44
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Lu1205 cells; 1 mM labeled precursors for eight hours; ornithine labeling required omission of extracellular proline. · source_derived_draft · unverified_draft
## l-proline-precursor-routing Two precursor routes can feed the same product through differently placed enzymes. Isotope tracing with gene silencing linked glutamine/glutamate-derived proline mainly to PYCR1/PYCR2 and ornithine-derived proline mainly to PYCRL in human melanoma cells. Model: Lu1205 cells; 1 mM labeled precursors for eight hours; ornithine labeling required omission of extracellular proline. Limitations: The ornithine experiment used conditions the authors regarded as likely nonphysiological; no universal exclusive routing rule is inferred. Evidence access: Primary full text Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
Complete structured claim and evidenceProline inhibited recombinant PYCR2 more strongly than PYCR1 or PYCRL; approximate apparent inhibition constants were 0.1, 0.6 and 8 mM, respectively.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Purified human enzymes; product-inhibition assays, with PYCR2 losing about 90% activity at 0.3 mM proline.
- limitations
- These assay concentrations are not blood targets or supplement recommendations.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Accumulating product can slow further production, with unequal sensitivity among enzymes.
- primary_references
- Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 46–52
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human enzymes; product-inhibition assays, with PYCR2 losing about 90% activity at 0.3 mM proline. · source_derived_draft · unverified_draft
## l-proline-product-feedback Accumulating product can slow further production, with unequal sensitivity among enzymes. Proline inhibited recombinant PYCR2 more strongly than PYCR1 or PYCRL; approximate apparent inhibition constants were 0.1, 0.6 and 8 mM, respectively. Model: Purified human enzymes; product-inhibition assays, with PYCR2 losing about 90% activity at 0.3 mM proline. Limitations: These assay concentrations are not blood targets or supplement recommendations. Evidence access: Primary full text Functional specialization in proline biosynthesis of melanoma. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23024808/ · DOI 10.1371/journal.pone.0045190
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.